Literature DB >> 12000718

Parkin localizes to the Lewy bodies of Parkinson disease and dementia with Lewy bodies.

Michael G Schlossmacher1, Matthew P Frosch, Wei Ping Gai, Miguel Medina, Nutan Sharma, Lysia Forno, Tomoyo Ochiishi, Hideki Shimura, Ronit Sharon, Nobutaka Hattori, J William Langston, Yoshikuni Mizuno, Bradley T Hyman, Dennis J Selkoe, Kenneth S Kosik.   

Abstract

Mutations in alpha-synuclein (alpha S) and parkin cause heritable forms of Parkinson disease (PD). We hypothesized that neuronal parkin, a known E3 ubiquitin ligase, facilitates the formation of Lewy bodies (LBs), a pathological hallmark of PD. Here, we report that affinity-purified parkin antibodies labeled classical LBs in substantia nigra sections from four related human disorders: sporadic PD, inherited alphaS-linked PD, dementia with LBs (DLB), and LB-positive, parkin-linked PD. Anti-parkin antibodies also detected LBs in entorhinal and cingulate cortices from DLB brain and alphaS inclusions in sympathetic gangliocytes from sporadic PD. Double labeling with confocal microscopy of DLB midbrain sections revealed that approximately 90% of anti-alpha S-reactive LBs were also detected by a parkin antibody to amino acids 342 to 353. Accordingly, parkin proteins, including the 53-kd mature isoform, were present in affinity-isolated LBs from DLB cortex. Fluorescence resonance energy transfer and immunoelectron microscopy showed that alphaS and parkin co-localized within brainstem and cortical LBs. Biochemically, parkin appeared most enriched in cytosolic and postsynaptic fractions of adult rat brain, but also in purified, alpha S-rich presynaptic elements that additionally contained parkin's E2-binding partner, UbcH7. We conclude that parkin and UbcH7 are present with alphaS in subcellular compartments of normal brain and that parkin frequently co-localizes with alpha S aggregates in the characteristic LB inclusions of PD and DLB. These results suggest that functional parkin proteins may be required during LB formation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000718      PMCID: PMC1850875          DOI: 10.1016/S0002-9440(10)61113-3

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  59 in total

1.  Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

Authors:  B P van de Warrenburg; M Lammens; C B Lücking; P Denèfle; P Wesseling; J Booij; P Praamstra; N Quinn; A Brice; M W Horstink
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

2.  Parkin is associated with actin filaments in neuronal and nonneural cells.

Authors:  D P Huynh; D R Scoles; T H Ho; M R Del Bigio; S M Pulst
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

3.  PSD-95 involvement in maturation of excitatory synapses.

Authors:  A E El-Husseini; E Schnell; D M Chetkovich; R A Nicoll; D S Bredt
Journal:  Science       Date:  2000-11-17       Impact factor: 47.728

4.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

5.  A ubiquitin-like system mediates protein lipidation.

Authors:  Y Ichimura; T Kirisako; T Takao; Y Satomi; Y Shimonishi; N Ishihara; N Mizushima; I Tanida; E Kominami; M Ohsumi; T Noda; Y Ohsumi
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

6.  Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase.

Authors:  H Shimura; N Hattori; S i Kubo; Y Mizuno; S Asakawa; S Minoshima; N Shimizu; K Iwai; T Chiba; K Tanaka; T Suzuki
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

7.  An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene.

Authors:  S Hayashi; K Wakabayashi; A Ishikawa; H Nagai; M Saito; M Maruyama; T Takahashi; T Ozawa; S Tsuji; H Takahashi
Journal:  Mov Disord       Date:  2000-09       Impact factor: 10.338

8.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.

Authors:  Y Zhang; J Gao; K K Chung; H Huang; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.

Authors:  W P Gai; H X Yuan; X Q Li; J T Power; P C Blumbergs; P H Jensen
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

10.  Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations.

Authors:  P J McLean; S Ribich; B T Hyman
Journal:  J Neural Transm Suppl       Date:  2000
View more
  76 in total

Review 1.  Etiology of Parkinson's disease: Genetics and environment revisited.

Authors:  Kathy Steece-Collier; Eleonora Maries; Jeffrey H Kordower
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-21       Impact factor: 11.205

2.  Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.

Authors:  Nozomi Hishikawa; Jun-Ichi Niwa; Manabu Doyu; Takashi Ito; Shinsuke Ishigaki; Yoshio Hashizume; Gen Sobue
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

3.  Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.

Authors:  Dongdong Yao; Zezong Gu; Tomohiro Nakamura; Zhong-Qing Shi; Yuliang Ma; Benjamin Gaston; Lisa A Palmer; Edward M Rockenstein; Zhuohua Zhang; Eliezer Masliah; Takashi Uehara; Stuart A Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

Review 4.  The Lewy body in Parkinson's disease and related neurodegenerative disorders.

Authors:  Koichi Wakabayashi; Kunikazu Tanji; Saori Odagiri; Yasuo Miki; Fumiaki Mori; Hitoshi Takahashi
Journal:  Mol Neurobiol       Date:  2012-05-24       Impact factor: 5.590

Review 5.  Protein degradation pathways in Parkinson's disease: curse or blessing.

Authors:  Darius Ebrahimi-Fakhari; Lara Wahlster; Pamela J McLean
Journal:  Acta Neuropathol       Date:  2012-06-29       Impact factor: 17.088

6.  Mutation analysis of the seven in absentia homolog 1 (SIAH1) gene in Parkinson's disease.

Authors:  T Franck; R Krueger; D Woitalla; T Müller; S Engelender; O Riess
Journal:  J Neural Transm (Vienna)       Date:  2006-06-06       Impact factor: 3.575

Review 7.  The application of NMR-based metabonomics in neurological disorders.

Authors:  Elaine Holmes; Tsz M Tsang; Sarah J Tabrizi
Journal:  NeuroRx       Date:  2006-07

Review 8.  Association of heat-shock proteins in various neurodegenerative disorders: is it a master key to open the therapeutic door?

Authors:  Subhankar Paul; Sailendra Mahanta
Journal:  Mol Cell Biochem       Date:  2013-10-05       Impact factor: 3.396

Review 9.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012

10.  TRIM9, a novel brain-specific E3 ubiquitin ligase, is repressed in the brain of Parkinson's disease and dementia with Lewy bodies.

Authors:  Kunikazu Tanji; Tetsu Kamitani; Fumiaki Mori; Akiyoshi Kakita; Hitoshi Takahashi; Koichi Wakabayashi
Journal:  Neurobiol Dis       Date:  2010-01-18       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.